Insider · CIK 0001669737

Dahan Michel

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001669737

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-13	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−34.8K sh	$1.26	−$43.9K	672,092
2024-02-29	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−8,661 sh	$1.58	−$13.7K	706,932
2024-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−10.7K sh	$1.52	−$16.3K	715,593
2024-01-31	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+149K sh	—	—	726,337
2024-01-31	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+224K sh	—	—	224,000
2023-05-25	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−95.5K sh	$1.22	−$117K	574,037
2023-05-24	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+200K sh	—	—	669,515
2023-05-24	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+200K sh	—	—	200,000
2023-05-12	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+200K sh	—	—	469,515
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−8,058 sh	$0.88	−$7,070.895	281,869
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−10.5K sh	$0.88	−$9,192.69	271,393
2023-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,878 sh	$0.88	−$1,647.945	269,515
2023-02-27	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−10.1K sh	$0.81	−$8,205.188	289,927
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−6,873 sh	$2.17	−$14.9K	302,122
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−6,873 sh	$2.17	−$14.9K	295,249
2022-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,232 sh	$2.17	−$2,674.302	297,017
2022-02-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−6,555 sh	$2.15	−$14.1K	258,995
2022-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+50K sh	—	—	308,995
2022-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+200K sh	—	—	200,000
2021-04-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,211 sh	$3.40	−$4,117.4	265,550
2021-03-16	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+11.6K sh	—	—	266,761
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−6,602 sh	$3.40	−$22.4K	263,058
2021-03-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−7,945 sh	$3.40	−$27K	255,113
2021-02-26	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+62K sh	—	—	269,660
2021-02-26	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+110K sh	—	—	110,000
2020-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+65K sh	—	—	211,932
2020-02-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−6,972 sh	$8.70	−$60.7K	204,960
2020-02-28	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+120K sh	—	—	120,000
2019-04-11	AKBAAkebia Therapeutics, Inc.D Disposition to Issuer	SVP, Chief Operating Officer	DDisposition to Issuer	−11.9K sh	$7.70	−$91.7K	146,932
2019-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+65K sh	—	—	158,841
2019-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+100K sh	—	—	100,000
2018-12-12	AKBAAkebia Therapeutics, Inc.F Tax Payment	SVP, Chief Operating Officer	FTax Payment	−23.4K sh	$8.94	−$209K	93,841
2018-02-28	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+19.4K sh	—	—	115,226
2018-02-28	AKBAAkebia Therapeutics, Inc. · Employee Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+27.5K sh	—	—	27,500
2017-10-02	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,398 sh	$19.64	−$27.5K	95,826
2017-09-28	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−5,000 sh	$19.30	−$96.5K	97,224
2017-08-15	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−5,000 sh	$15.00	−$75K	102,224
2017-07-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,399 sh	$14.26	−$19.9K	107,224
2017-04-03	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,401 sh	$9.18	−$12.9K	108,623
2017-02-21	AKBAAkebia Therapeutics, Inc.A Award	SVP, Chief Operating Officer	AAward	+39.5K sh	—	—	110,024
2017-02-21	AKBAAkebia Therapeutics, Inc. · Stock Option (Right to buy)A Award	SVP, Chief Operating Officer	AAward	+62.5K sh	$10.14	+$634K	62,500
2017-01-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,629 sh	$10.49	−$17.1K	70,524
2016-10-01	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,401 sh	$8.95	−$12.5K	72,153
2016-07-05	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,402 sh	$7.47	−$10.5K	73,554
2016-04-04	AKBAAkebia Therapeutics, Inc.S Sale	SVP, Chief Operating Officer	SSale	−1,401 sh	$9.41	−$13.2K	74,956

Recent filings

Accepted (ET)
May 144
Dahan Michel0001562180-24-004025
SEC(opens sec.gov)
Mar 14
Dahan Michel0001562180-24-002023
SEC(opens sec.gov)
Feb 294
Dahan Michel0001562180-24-001994
SEC(opens sec.gov)
Feb 24
Dahan Michel0001562180-24-000978
SEC(opens sec.gov)
May 254
Dahan Michel0001562180-23-004503
SEC(opens sec.gov)
May 164
Dahan Michel0001562180-23-004168
SEC(opens sec.gov)
Mar 34
Dahan Michel0001562180-23-002198
SEC(opens sec.gov)
Mar 14
Dahan Michel0001562180-23-002039
SEC(opens sec.gov)
Mar 24
Dahan Michel0001562180-22-002163
SEC(opens sec.gov)
Apr 14
Dahan Michel0001562180-21-002541
SEC(opens sec.gov)

Companies

Akebia Therapeutics, Inc.SVP, Chief Operating OfficerAKBA

Address

C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100

CAMBRIDGE, MA, 02142